glp-1 hearing loss The promise and peril of GLP-1 agonists: What we do (and don't) know as of August 2024 Common Medications That Affect Hearing

What the Tirzepatide Labels Say About Timing Both approved tirzepatide products are administered subcutaneously once weekly, at any time of day, with or without meals

By targeting this pathway, 5-Amino 1MQ has become a compound of interest in advanced metabolic, weight-management, and longevity-focused research settings

These agents are being studied across both first and second line, with subcutaneous, oral, and novel routes of administration (ROAs)

Li Q, Taegtmeyer H, Wang ZV

In another study, thiamine therapy leads to the disappearance of both gastrointestinal (dysphagia) and CNS/cardiovascular (dyspnea and blurred vision) symptoms

A $30 million business development pipeline in biotech has been secured through partnerships over the next 24 months